These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4658529)

  • 41. [Results of the treatment of selected dermologic diseases with 0.2 per cent Synalar cream].
    Mazurkiewicz W; Koźmińska A
    Przegl Dermatol; 1969; 56(3):339-44. PubMed ID: 5343936
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical experiments on the topical use of fluocinolone acetonide in propylene glycol].
    Vignali C
    Arcisp S Anna Ferrara; 1966; 19(4):535-40. PubMed ID: 5959876
    [No Abstract]   [Full Text] [Related]  

  • 43. [Occlusive therapy of dermatosis with fluocinolone acetonide].
    Armentano E
    Clin Ter; 1967 Jul; 42(2):141-6. PubMed ID: 5596412
    [No Abstract]   [Full Text] [Related]  

  • 44. Corticosteroid bioavailability assays. Correlation with a clinical study.
    Burdick KH
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):19-23. PubMed ID: 5291630
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical evaluation of 0.01 per cent solution of fluocinolone acetonide in propylene glycol].
    Aceves Ortega R
    Medicina (Mex); 1965 Apr; 45(962):171-6. PubMed ID: 5837268
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical use of betamethasone-gentamicin].
    Kobori T; Kinebuchi S
    Acta Dermatol Kyoto Engl Ed; 1968 May; 63(2):181-94. PubMed ID: 5755359
    [No Abstract]   [Full Text] [Related]  

  • 47. Evaluation of a new corticosteroid, fluocinonide, in a scientifically designed base.
    Burdick KH
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):24-31. PubMed ID: 5291631
    [No Abstract]   [Full Text] [Related]  

  • 48. [Further observations with fluocinolone acetonide in local administration].
    Gatti JC; Cardama JE; Avila JJ; Carnevale Benino de Gar
    Prensa Med Argent; 1966 Sep; 53(35):1919-20. PubMed ID: 6011708
    [No Abstract]   [Full Text] [Related]  

  • 49. Therapeutic respnonses to fluocinolone acetonide of increased concentration.
    Krasner F
    N Y State J Med; 1969 Feb; 69(3):466-8. PubMed ID: 5253305
    [No Abstract]   [Full Text] [Related]  

  • 50. [The experience of Soviet dermatologists with the therapeutic use of Synalar].
    Danda
    Cesk Dermatol; 1967 Feb; 42(1):71. PubMed ID: 6040741
    [No Abstract]   [Full Text] [Related]  

  • 51. [FLUOCINOLONE ACETONIDE (0.01 PER CENT) UNDER OCCLUSIVE DRESSING: THERAPEUTIC VALUE IN DERMATOLOGY OF THIS NEW PRODUCT IN WEAK CONCENTRATION].
    BAZEX A; DUPRE A; CHRISTOL B
    Presse Med (1893); 1964 Oct; 72():2387-8. PubMed ID: 14187775
    [No Abstract]   [Full Text] [Related]  

  • 52. High concentration fluocinolone cream in the management of resistant dermatoses.
    Imperato PJ; Callaway JL
    N C Med J; 1967 Jul; 28(7):276-8. PubMed ID: 5233064
    [No Abstract]   [Full Text] [Related]  

  • 53. [Complications in the course of the treatment of rosacea with fluocinolone acetonide (Synalar ointment].
    Mazurkiewicz W; Dabrowska H; Wnorowski J; Chadzynska M
    Przegl Dermatol; 1971; 58(3):297-305. PubMed ID: 4257400
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical study of the combination of 17-betamethasone valerate-gentamicin in dermatology].
    Grigoriu D
    Schweiz Rundsch Med Prax; 1970 Jul; 59(29):1070-1. PubMed ID: 5512657
    [No Abstract]   [Full Text] [Related]  

  • 55. [Flubenisolonvalerate and fluocinolonacetonide in the treatment of skin diseases. A double-blind study].
    Thomsen K
    Ugeskr Laeger; 1966 Nov; 128(47):1391-3. PubMed ID: 5342507
    [No Abstract]   [Full Text] [Related]  

  • 56. [Results of treatment with synalar ointment].
    Koźmińska A; Pawlowski A
    Przegl Dermatol; 1966; 53(2):193-6. PubMed ID: 5943977
    [No Abstract]   [Full Text] [Related]  

  • 57. [Topical treatment of alopecia areata--a double blind test using 0.025 per cent and 1.2 per cent fluocinolone acetonide cream].
    Azumi T; Sasada K; Yasue A; Watanabe T
    Hifuka Kiyo; 1971 Feb; 66(1):63-79. PubMed ID: 4948970
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical trial of synalar ointment].
    Sourreil P; Beylot C
    J Med Bord; 1967 Mar; 144(3):457-64. PubMed ID: 5609719
    [No Abstract]   [Full Text] [Related]  

  • 59. [Treatment of psoriasis with Synalar ointment].
    Chowaniec O
    Przegl Dermatol; 1973; 60(2):234-8. PubMed ID: 4791679
    [No Abstract]   [Full Text] [Related]  

  • 60. [Therapeutic effects of flucort solution in skin diseases].
    Watanabe S; Yamada M; Aoshima T
    Acta Dermatol Kyoto Engl Ed; 1968 May; 63(2):195-9. PubMed ID: 5755360
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.